Background The relative effectiveness of second-generation (atypical) antipsychotic drugs
as compared with that of older agents has been incompletely addressed, though newer …

~ Maior depression is a frequent and disabling psychiatric disorder in the United States.
This report exam ines the prevalence and risk factor profile ofboth pure and comorbid major …

Context Neurocognitive impairment in schizophrenia is severe and is an important predictor
of functional outcome. The relative effect of the second-generation (atypical) antipsychotic …

Objective: When a schizophrenia patient has an inadequate response to treatment with an
antipsychotic drug, it is unclear what other antipsychotic to switch to and when to use …

… Dr Swartz has received research funding from Eli Lilly; and consulting and educational
fees from AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Eli Lilly, and Pfizer Inc. Dr …

OBJECTIVE: Violent behavior among individuals with severe mental illness has become an
important focus in community-based care. This study examines the joint effect of substance …

OBJECTIVES: This study assessed seroprevalence rates of HIV, hepatitis B virus (HBV),
and hepatitis C virus (HCV) among individuals with severe mental illness. METHODS: …

… and the rationales for their selection appear in the article by Swartz et al. in this issue. …
Swartz is Co-PI of the CATTE Clinical and Functional Assessment Unit. Drs. Byerly, Glick, Canive, …

… Swartz has served as a consultant for Eli Lilly and Co. Dr. Swanson has received grant/…
Swanson JW, Swartz MS, Elbogen E. Effectiveness of atypical antipsychotic medications in …

In 2002, a University of Wisconsin student brought a prescription for Loestrin to pharmacist
Neil Noesen, who was working in a local community pharmacy in Menomonie, Wisconsin. …